Shanghai NewMed Medical Raises $100 Million for Heart Repair Devices

NewMed Medical Company of Shanghai closed a $100 million Series C round led by Singapore 's Temasek. Established in 2015, NewMed develops interventional medical devices for structural heart disease. It has minimally invasive transcatheter devices in clinical trials for mitral valve replacement, mitral valve repair and aortic valve replacement, along with auxiliary equipment for the procedures. It is also developing additional innovative devices for heart repair. New investors in the C round include YF Capital and Chengwei Chuangban Fund. More details.... Share this with colleagues: // //